The safety and quality of allograft bio-implants are critical to physicians and their patients. As a leading regenerative medicine company, LifeNet Health has developed a full suite of technologies to ensure these needs are met with every bio-implant we provide.
LifeNet Health offers four allograft bio-implant technologies every surgeon should take note of:
This patented and validated process renders allograft bio-implant tissue acellular; without compromising the biomechanical or desired biochemical properties of an allograft bio-impant surgical application.1
Our proprietary, glycerol-based preservation solution allows bio-implants to be stored in a fully hydrated state at ambient temperature.2 This eliminates the need for lengthy rehydration, and saves valuable OR time.
Our demineralization technology provides precise bone demineralization to achieve the ideal residual calcium level of 1 to 4%. This controlled process protects bone morphogenetic proteins (BMPs) while ensuring optimal osteoinductivity.3
- ALLOWASH XG®
For optimal safety, Allowash XG is a 6 step process which addresses bioburden to provide medical implant level of sterility while maintaining the biomechanical and biochemical properties of our allografts.4-5
- Data on File at LifeNet Health: TR-0082, TR-0119, and TR-0148
- Graham R, et al. Evaluation of Glycerol-Preserved Bone Allografts in Cervical Spine Fusion: A Prospective, Randomized Controlled Trial. J Neurosurg Spine. 2015;22.1: 1-10
- Zhang M, Powers RM Jr, Wolfinbarger L Jr. Effect(s) of the demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol. 1997 Nov;68(11):1085-92
- Moore MA. Inactivation of enveloped and non-enveloped viruses on seeded human tissues by gamma irradiation. Cell Tissue Bank. 2012 Aug;13(3):401-7. doi: 10.1007/s10561-011-9266-0.
Data on File at LifeNet Health: TR-0020 & TR-0023